NSAID-induced apoptosis in Rous sarcoma virus-transformed chicken embryo fibroblasts is dependent on v-src and c-myc and is inhibited by bcl-2

Prostaglandins

Volumn 54, Issue 2, 1997, Pages 549-568

  Lu, Xiaojun ^b   Fairbairn, Daryl W ^b   Bradshaw, William S ^b   O'Neill, Kim L ^b   Ewert, Donald L ^c   Simmons, Daniel L ^a  

^a Brigham Young University   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

Aspirin like drugs; Bcl 2; C myc; Fibroblasts; NSAID; Rous sarcoma virus; V src

Indexed keywords

ACEMETACIN; CARPROFEN; CYCLOOXYGENASE 2; DICLOFENAC; DIFLUNISAL; DOUBLE STRANDED DNA; FLUFENAMIC ACID; INDOMETACIN; MEFENAMIC ACID; MESSENGER RNA; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL 2; PROTEIN KINASE P60; PROTEIN P53; SINGLE STRANDED DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; DNA CLEAVAGE; DNA DETERMINATION; DRUG ACTIVITY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C MYC; ONCOGENE SRC; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ROUS SARCOMA ONCOVIRUS; VIRUS CELL TRANSFORMATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; AVIAN SARCOMA VIRUSES; CELL LINE, TRANSFORMED; CHICK EMBRYO; DNA FRAGMENTATION; FIBROBLASTS; GENE EXPRESSION; GENES, MYC; HUMANS; ONCOGENE PROTEIN PP60(V-SRC); PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0030753297     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(97)00125-1     Document Type: Article

References (45)

1. Marnett L.J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52:1992;5575-5589.
2. Xie W., Robertson D.L., Simmons D.L. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res. 25:1992;249-265.
3. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
4. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
5. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
6. Sano H., Yutaka K., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
7. Talamonti M.S., Roh M.S., Curley S.A., Gallick G.E. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J. Clin. Invest. 91:1993;53-60.
8. Xie W., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88:1991;2692-2696.
9. Lu X., Xie W., Reed D., Bradshaw W.S., Simmons D.L. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA. 92:1995;7961-7965.
10. Hanafusa H. Rapid transformation of cells by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA. 63:1969;318-325.
11. Mayer B.J., Jove R., Krane J.F., Poirier F., Calothy G., Hanafusa H. Genetic lesions involved in temperature sensitivity of the. src gene products of four Rous sarcoma virus mutants J. Virol. 60:1986;858-867.
12. Olive P.L., Wlodek D., Durand R.E., Banath J.P. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp. Cell Res. 198:1992;259-267.
13. Fairbairn D.W., Olive P.L., O'Neill K.L. The comet assay: a comprehensive review. Mutation Res. 339:1995;37-59.
14. Olive P.L., Wlodek D., Banath J.P. DNA double-strand breakage and DNA structure influence staining with propidium iodide using the alkaline comet assay. Cancer Res. 51:1991;4671-4676.
15. Zar, J.H. Biostatistical Analysis . Englewood Cliffs, NJ: Prentice-Hall. 1984.
16. Chirgwin J.M., Przbyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
17. Church G.M., Gilbert W. Genomic Sequencing. Proc. Nat. Acad. Sci. USA. 81:1984;1991-1995.
18. Watson D.K., Reddy E.P., Duesberg P.H., Papas T.S. Nucleotide sequence analysis of the chicken c-. myc gene reveals homologous and unique coding regions by comparison with the transforming gene of avian myelocytomatosis virus MC29, Δgag-myc Proc. Natl. Acad. Sci. USA. 80:1983;2146-2150.
19. Cazals-Hatem D.L., Louie D.C., Tanaka S., Reed J.C. Molecular cloning and DNA sequence analysis of cDNA encoding the chicken homologue of the Bcl-2 oncoprotein. Biochim. Biophys. Acta. 1132:1992;109-113.
20. Soussi T., Begue A., Kress M., Stehlen D., May P. Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. Nucleic Acid Res. 16:1988;11383.
21. Givol I., Tsarfaty I., Raesau J., Shen R., da Silva P.P., Nasioulas G., DuHadaway J., Hughes S.H., Ewert D.L. Bcl-2 expressed using a retroviral vector is localized primarily in the nuclear membrane and the endoplasmic reticulum of chicken embryo fibroblasts. Cell Growth and Differ. 5:1994;419-429.
22. Wu K.K., Sanduja R., Tsai A.-L., Ferhanoglu B., Loose-Mitchell D.S. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;2384-2387.
23. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
24. Picot D., Loll P.J., Garavito R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase. Nature. 367:1994;243-249.
25. Loll P., Picot D., Garavito R.M. Nat. Struct. Biol. 2:1995;637-643.
26. Garavito, R.M. Improved Non-steroid Anti-inflammatory Drugs: COX-2 Enzyme Inhibitors. pp29-44. Kluwer Academic Publishers, London, 1996.
27. Shiff S.J., Qiao L., Tsai L.-L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
28. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Stainano-Coico L., Shiff S.I., Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245.
29. Simmons, D.L., Madsen, M.L., and Robertson, P.M. COX-2 and Apoptosis: NSAIDs as effectors of programmed cell death. In Selective COX-2 Inhibitors: Pharmacology, Clinical Effects, and Therapeutic Potential; J. Vane and J Botting eds, Kluwer Academic Publishers, London (in press).
30. Piazza G.A., Rahm A.L.K., Krutzsch M., Sperl G., Paranka N.S., Gross P.H., Brendel K., Burt R.W., Alberts D.S., Pamukcu R., Ahnen D.J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Research. 55:1995;3110-3116.
31. Thompson H.J., Jiang C., Lu J., Mehta R.G., Piazza G.A., Paranka N.S., Pamuckcu R., Ahnen D.J. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Research. 57:1997;267-271.
32. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Research. 55:1995;1464-1472.
33. Lehman J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
34. Ledwith B.J., Pauley C.J., Wagner L.K., Rokos C.L., Alberts D.W., Manam S. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promoters in immortalized mouse liver cells. J. Biol. Chem. 272:1997;3707-3714.
35. Green S. PPAR: a mediator of peroxisome proliferator action. Mutation Res. 333:1995;101-109.
36. Barone M.V., Courtneidge S.A. Myc but not fos rescue of PDGF signalling block caused by kinase-inactive src. Nature. 378:1995;509-512.
37. Lee H., Arsura M., Wu M., Duyao M., Buckler A.J., Sonenshein G.E. Role of rel-related factors in control of c-myc gene trasncription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1995;1169-1177.
38. Hawkins C.J., Vaux D.L. Analysis of the role of bcl-2 in apoptosis. Immunol. Reviews. 142:1994;127-139.
39. Oren M. Relationship of p53 to the control of apoptotic cell death. Sem. Cancer Biol. 5:1994;221-227.
40. Shen Y., Shenk T.E. Viruses and apoptosis. Curr. Opin. Genet. Develop. 5:1995;105-111.
41. Harrington E.A., Fanidi A., Evan G.I. Oncogenes and cell death. Curr. Opin. Genet. Develop. 4:1994;120-129.
42. Evett G.E., Xie W., Chipman J.G., Robertson D.L., Simmons D.L. Prostaglandin G/H synthase isoenzyme-2 expression in fibroblasts: regulation by dexamethasone, mitogens and oncogens. Arch. Biochem. Biophys. 306:1993;169-177.
43. Kutchera W., Jones D.A., Matsunami N., Groden J., McIntyre T.M., Zimmerman G.A., White R.L., Prescott S.M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA. 93:1996;4816-4820.
44. Bronner M.P., Culin C., Reed J.C., Furth E.E. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am. J. Pathol. 146:1995;20-26.
45. Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.